These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9241570

  • 1. Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.
    Tome MB, Cloninger CR, Watson JP, Isaac MT.
    J Affect Disord; 1997 Jul; 44(2-3):101-9. PubMed ID: 9241570
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F.
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [Abstract] [Full Text] [Related]

  • 3. Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency.
    Tome MB, Isaac MT, Harte R, Holland C.
    Int Clin Psychopharmacol; 1997 Mar; 12(2):81-9. PubMed ID: 9219043
    [Abstract] [Full Text] [Related]

  • 4. Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique.
    Bordet R, Thomas P, Dupuis B.
    Am J Psychiatry; 1998 Oct; 155(10):1346-51. PubMed ID: 9766765
    [Abstract] [Full Text] [Related]

  • 5. How long should pindolol be associated with paroxetine to improve the antidepressant response?
    Zanardi R, Artigas F, Franchini L, Sforzini L, Gasperini M, Smeraldi E, Perez J.
    J Clin Psychopharmacol; 1997 Dec; 17(6):446-50. PubMed ID: 9408806
    [Abstract] [Full Text] [Related]

  • 6. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G, Schmitt A, Chereau I, Eschalier A, Dubray C, Llorca PM.
    Encephale; 2003 Dec; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [Abstract] [Full Text] [Related]

  • 7. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A, Corruble E.
    Encephale; 2002 Dec; 28(4):363-73. PubMed ID: 12232546
    [Abstract] [Full Text] [Related]

  • 8. Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
    Perry EB, Berman RM, Sanacora G, Anand A, Lynch-Colonese K, Charney DS.
    J Clin Psychiatry; 2004 Feb; 65(2):238-43. PubMed ID: 15003079
    [Abstract] [Full Text] [Related]

  • 9. Paroxetine with pindolol augmentation: a double-blind, randomized, placebo-controlled study in depressed in-patients.
    Geretsegger C, Bitterlich W, Stelzig R, Stuppaeck C, Bondy B, Aichhorn W.
    Eur Neuropsychopharmacol; 2008 Feb; 18(2):141-6. PubMed ID: 18054209
    [Abstract] [Full Text] [Related]

  • 10. The influence of personality factors on paroxetine response time in patients with major depression.
    Kaneda A, Yasui-Furukori N, Nakagami T, Sato Y, Kaneko S.
    J Affect Disord; 2011 Dec; 135(1-3):321-5. PubMed ID: 21784533
    [Abstract] [Full Text] [Related]

  • 11. One year real world prospective follow-up study of a major depressive episode of patients treated with paroxetine and pindolol or paroxetine for 6 weeks.
    Tome MB, Isaac MT.
    Int Clin Psychopharmacol; 1998 Jul; 13(4):169-74. PubMed ID: 9727727
    [Abstract] [Full Text] [Related]

  • 12. Cost effectiveness study of a year follow-up of selective serotonin reuptake inhibitor (SSRI) and augmentor combination compared with SSRI and placebo.
    Tome MB, Isaac MT.
    Int Clin Psychopharmacol; 1998 Jul; 13(4):175-82. PubMed ID: 9727728
    [Abstract] [Full Text] [Related]

  • 13. Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies.
    Martinez D, Broft A, Laruelle M.
    Biol Psychiatry; 2000 Oct 15; 48(8):844-53. PubMed ID: 11063979
    [Abstract] [Full Text] [Related]

  • 14. Once-daily high-dose pindolol for paroxetine-refractory premature ejaculation: a double-blind, placebo-controlled and randomized study.
    Safarinejad MR.
    J Clin Psychopharmacol; 2008 Feb 15; 28(1):39-44. PubMed ID: 18204339
    [Abstract] [Full Text] [Related]

  • 15. Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache.
    Boz C, Gazioglu S, Altunayoglu V, Hocaoglu C.
    Psychiatry Clin Neurosci; 2007 Oct 15; 61(5):534-42. PubMed ID: 17875033
    [Abstract] [Full Text] [Related]

  • 16. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial.
    Dannon PN, Sasson Y, Hirschmann S, Iancu I, Grunhaus LJ, Zohar J.
    Eur Neuropsychopharmacol; 2000 May 15; 10(3):165-9. PubMed ID: 10793318
    [Abstract] [Full Text] [Related]

  • 17. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P, Bergeron R, de Montigny C.
    Neuropsychopharmacology; 1997 May 15; 16(5):333-8. PubMed ID: 9109104
    [Abstract] [Full Text] [Related]

  • 18. What is the effect of selective serotonin reuptake inhibitors on temperament and character in patients with fibromyalgia?
    Mazza M, Mazza O, Pomponi M, Di Nicola M, Padua L, Vicini M, Bria P, Mazza S.
    Compr Psychiatry; 2009 May 15; 50(3):240-4. PubMed ID: 19374968
    [Abstract] [Full Text] [Related]

  • 19. Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder.
    Tomita T, Kaneda A, Nakagami T, Kaneko S, Yasui-Furukori N.
    Hum Psychopharmacol; 2015 Sep 15; 30(5):334-40. PubMed ID: 25845342
    [Abstract] [Full Text] [Related]

  • 20. Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers.
    Bell C, Wilson S, Rich A, Bailey J, Nutt D.
    Psychopharmacology (Berl); 2003 Mar 15; 166(2):102-10. PubMed ID: 12536263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.